HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 82 filers reported holding HARVARD BIOSCIENCE INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,180 | -21.7% | 2,600 | 0.0% | 0.00% | – |
Q2 2023 | $14,274 | +30.7% | 2,600 | 0.0% | 0.00% | – |
Q1 2023 | $10,920 | +51.6% | 2,600 | 0.0% | 0.00% | – |
Q4 2022 | $7,202 | +2.9% | 2,600 | 0.0% | 0.00% | – |
Q3 2022 | $7,000 | -22.2% | 2,600 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -43.8% | 2,600 | 0.0% | 0.00% | – |
Q1 2022 | $16,000 | -11.1% | 2,600 | 0.0% | 0.00% | – |
Q4 2021 | $18,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q3 2021 | $18,000 | -18.2% | 2,600 | 0.0% | 0.00% | – |
Q2 2021 | $22,000 | +57.1% | 2,600 | 0.0% | 0.00% | – |
Q1 2021 | $14,000 | +27.3% | 2,600 | 0.0% | 0.00% | – |
Q4 2020 | $11,000 | +37.5% | 2,600 | 0.0% | 0.00% | – |
Q3 2020 | $8,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +33.3% | 2,600 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | -25.0% | 2,600 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q3 2019 | $8,000 | +60.0% | 2,600 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -54.5% | 2,600 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | +37.5% | 2,600 | 0.0% | 0.00% | – |
Q4 2018 | $8,000 | -42.9% | 2,600 | 0.0% | 0.00% | – |
Q3 2018 | $14,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q2 2018 | $14,000 | +7.7% | 2,600 | 0.0% | 0.00% | – |
Q1 2018 | $13,000 | +44.4% | 2,600 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | +12.5% | 2,600 | 0.0% | 0.00% | – |
Q4 2016 | $8,000 | +14.3% | 2,600 | 0.0% | 0.00% | – |
Q3 2016 | $7,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q2 2016 | $7,000 | -12.5% | 2,600 | 0.0% | 0.00% | – |
Q1 2016 | $8,000 | -11.1% | 2,600 | 0.0% | 0.00% | – |
Q4 2015 | $9,000 | -10.0% | 2,600 | 0.0% | 0.00% | – |
Q3 2015 | $10,000 | -33.3% | 2,600 | 0.0% | 0.00% | – |
Q2 2015 | $15,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q1 2015 | $15,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q4 2014 | $15,000 | +36.4% | 2,600 | 0.0% | 0.00% | – |
Q3 2014 | $11,000 | -8.3% | 2,600 | 0.0% | 0.00% | – |
Q2 2014 | $12,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q1 2014 | $12,000 | -33.3% | 2,600 | -31.6% | 0.00% | – |
Q4 2013 | $18,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |